- Home
- RAYA vs PROK Comparison
RAYA vs PROK Comparison
Compare RAYA & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- PROK
- Stock Information
- Founded
- RAYA 2019
- PROK 2015
- Country
- RAYA China
- PROK United States
- Employees
- RAYA N/A
- PROK N/A
- Industry
- RAYA Metal Fabrications
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RAYA Consumer Discretionary
- PROK Health Care
- Exchange
- RAYA Nasdaq
- PROK Nasdaq
- Market Cap
- RAYA 89.2M
- PROK 85.5M
- IPO Year
- RAYA 2022
- PROK N/A
- Fundamental
- Price
- RAYA $2.47
- PROK $4.34
- Analyst Decision
- RAYA
- PROK Buy
- Analyst Count
- RAYA 0
- PROK 4
- Target Price
- RAYA N/A
- PROK $5.33
- AVG Volume (30 Days)
- RAYA 252.3K
- PROK 28.3M
- Earning Date
- RAYA 01-01-0001
- PROK 08-08-2025
- Dividend Yield
- RAYA N/A
- PROK N/A
- EPS Growth
- RAYA N/A
- PROK N/A
- EPS
- RAYA N/A
- PROK N/A
- Revenue
- RAYA $30,300,360.00
- PROK $306,000.00
- Revenue This Year
- RAYA $20.95
- PROK $54.34
- Revenue Next Year
- RAYA N/A
- PROK N/A
- P/E Ratio
- RAYA N/A
- PROK N/A
- Revenue Growth
- RAYA 49.10
- PROK N/A
- 52 Week Low
- RAYA $0.56
- PROK $0.46
- 52 Week High
- RAYA $3.14
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- RAYA 58.75
- PROK 90.68
- Support Level
- RAYA $2.31
- PROK $0.54
- Resistance Level
- RAYA $3.14
- PROK $0.73
- Average True Range (ATR)
- RAYA 0.37
- PROK 0.59
- MACD
- RAYA 0.03
- PROK 0.34
- Stochastic Oscillator
- RAYA 57.82
- PROK 57.66
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.